PSMA-Lu177
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PSMA-Lu177, covering 2025-02-10 to 2025-02-10. Get the full timeline:
Most recent: Clinical Trial Update: The Evaluation of the Effectiveness, Safety and Tolerability of Treatment, Using a PSMA-Lu177, in Patients with ACC- an Open, Non-commercial Clinical Trial [Phase 2]